PMID- 37943488 OWN - NLM STAT- Publisher LR - 20231109 IS - 1993-0402 (Electronic) IS - 1672-0415 (Linking) DP - 2023 Nov 9 TI - Honokiol Prevents Intestinal Barrier Dysfunction in Mice with Severe Acute Pancreatitis and Inhibits JAK/STAT1 Pathway and Acetylation of HMGB1. LID - 10.1007/s11655-023-3562-y [doi] AB - OBJECTIVE: To investigate the effect of honokiol (HON) and the role of high-mobility group protein B1 (HMGB1) on the pathogenesis of severe acute pancreatitis (SAP). METHODS: Thirty mice were numbered according to weight, and randomly divided into 5 groups using a random number table, including control, SAP, SAP and normal saline (SAP+NS), SAP and ethyl pyruvate (SAP+EP), or SAP+HON groups, 6 mice in each group. Samples of pancreas, intestine, and blood were collected 12 h after SAP model induction for examination of pathologic changes, immune function alterations by enzyme linked immunosorbent assay (ELISA), and Western blot. In vitro experiments, macrophages were divided into 5 groups, the control, lipopolysaccharide (LPS), LPS+DMSO (DMSO), LPS+anti-HMGB1 monoclonal antibody (mAb), and LPS+ HON groups. The tight connection level was determined by transmission electron microscopy and fluorescein isothiocyanate-labeled. The location and acetylation of HMGB1 were measured by Western blot. Finally, pyridone 6 and silencing signal transducer and activator of the transcription 1 (siSTAT1) combined with honokiol were added to determine whether the Janus kinase (JAK)/ STAT1 participated in the regulation of honokiol on HMGB1. The protein expression levels of HMGB1, JAK, and STAT1 were detected using Western blot. RESULTS: Mice with SAP had inflammatory injury in the pancreas, bleeding of intestinal tissues, and cells with disrupted histology. Mice in the SAP+HON group had significantly fewer pathological changes. Mice with SAP also had significant increases in the serum levels of amylase, lipase, HMGB1, tumor necrosis factor- alpha, interleukin-6, diamine oxidase, endotoxin-1, and procalcitonin. Mice in the SAP+HON group did not show these abnormalities (P<0.01). Studies of Caco-2 cells indicated that LPS increased the levels of occludin and claudin-1 as well as tight junction permeability, decreased the levels of junctional adhesion molecule C, and elevated intercellular permeability (P<0.01). HON treatment blocked these effects. Studies of macrophages indicated that LPS led to low nuclear levels of HMGB1, however, HON treatment increased the nuclear level of HMGB1 (P<0.01). HON treatment also inhibited the expressions of JAK1, JAK2, and STAT1 (P<0.01) and increased the acetylation of HMGB1 (P<0.05). CONCLUSION: HON prevented intestinal barrier dysfunction in SAP by inhibiting HMGB1 acetylation and JAK/STAT1 pathway. CI - (c) 2023. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature. FAU - Li, Jie AU - Li J AD - Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China. FAU - Chen, Ya-Feng AU - Chen YF AD - Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China. FAU - Gao, Lei AU - Gao L AD - Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China. FAU - Li, Yi-Jie AU - Li YJ AD - Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China. FAU - Feng, Dian-Xu AU - Feng DX AD - Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China. fdianxu@163.com. LA - eng PT - Journal Article DEP - 20231109 PL - China TA - Chin J Integr Med JT - Chinese journal of integrative medicine JID - 101181180 SB - IM OTO - NOTNLM OT - Janus kinase OT - high-mobility group protein B1 OT - honokiol OT - intestinal barrier dysfunction OT - severe acute pancreatitis OT - signal transducer and activator of transcription 1 EDAT- 2023/11/09 12:42 MHDA- 2023/11/09 12:42 CRDT- 2023/11/09 11:15 PHST- 2023/07/17 00:00 [accepted] PHST- 2023/11/09 12:42 [medline] PHST- 2023/11/09 12:42 [pubmed] PHST- 2023/11/09 11:15 [entrez] AID - 10.1007/s11655-023-3562-y [pii] AID - 10.1007/s11655-023-3562-y [doi] PST - aheadofprint SO - Chin J Integr Med. 2023 Nov 9. doi: 10.1007/s11655-023-3562-y.